Find the Perfect Plan for Your Investment Journey
A
Latest price
52 Week Range
HK$45.75 - HK$82.80
Next Earnings Date
Jun 27 2025 (Estimate)
Next Earnings Date
Jun 27 2025 (Est.)
Latest price
Market Cap | HK$8.59B |
EV | HK$5.36B |
Shares Outstanding | 170.03M |
Beta | 1.18 |
Analyst Rating | BUY |
Analyst Target Price | HK$79.76 |
P/E 2025E | 93.50x |
P/Revenue 2025E | 3.50x |
Revenue | 15.20% |
EPS | -37.20% |
Operating Cash Flow | -34.80% |
Free Cash Flow | - |
Revenue | 18.80% |
EPS | 34.40% |
Operating Cash Flow | 39.20% |
Free Cash Flow | - |
Gross Margin 2025E | 59.29% |
Net Profit Margin 2025E | 3.74% |
ROE 2025E | 2.81% |
ROCE 2024 | 2.60% |
DPS 2025E | HK$1.57 |
Payout Ratio 2025E | 290.74% |
Div. Yield 2025E | 3.11% |
DPS Last 3Y CAGR | - |
Price
%
1M
3M
6M
1Y
3Y
5Y
A
Angelalign Technology Inc.
6699
Sector
Healthcare
Industry
Medical - Instruments & Supplies
CEO
Hu, Jiezhang
Employees
3,576
Website
www.angelalign.comIPO Date
2021-06-16
Headquarters
No. 7, KIC Business Center, 6/F-7/F, No. 500 Zhengli Road, Yangpu District, Shanghai China
COMPANY
NEWSLETTER
© Copyright 2025, All Rights Reserved